Post-earnings recap
Reported
Wed, Oct 29, 2014
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Charles River Laboratories reported an EPS of $0.86, exceeding expectations by 8.04%. The stock reacted positively, rising by 0.66%. However, without additional context from management commentary or guidance, it's difficult to assess the longer-term implications of these results.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.86 | N/A | +8.04% |
No transcript is on record, and the analysis is based solely on numerical results.